Wegovy is contraindicated during pregnancy and breastfeeding, and should not be used in combination with other GLP-1 receptor agonists or weight-loss medicines
GLP-1 receptor agonists improve insulin sensitivity and glucose control
While many patients are concerned about potential interactions between weight loss injections and their birth control methods, current clinical evidence suggests that semaglutide does not directly interfere with the chemical efficacy of hormonal IUDs, such as the Mirena
By delivering vitamin C directly into the bloodstream, IV infusions bypass the digestive system, allowing for better absorption
FDA-approved semaglutide products are available, and patients should review all options with a healthcare professional
Semaglutide is a once-weekly GLP-1RA injection and approved for treatment of adults with T2DM and is known for its high potency in reducing HbA1c, weight and blood pressure